Fractionated radioimmunotherapy with I-131-labeled chimeric antibody G250 (cG250) in patients with metastatic renal cell carcinoma.

被引：0
|
作者：
Divgi, CR
O'Donoghue, JA
McGagh, DA
Motzer, RJ
Anwar, K
Sheikh, A
Gonzalez, RS
Welt, S
Old, LJ
Larson, SM
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Ludwig Inst Canc Res, New York, NY USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 1999年 / 40卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
970
引用
收藏
页码：217P / 217P
页数：1
相关论文
共 50 条
  • [1] Fractionated radioimmunotherapy with I-131 chimeric antibody G250 (cG250) in metastatic renal cancer
    Divgi, CR
    O'Donoghue, JA
    McGagh, D
    Anwar, K
    Motzer, R
    Welt, S
    Larson, SM
    Old, LJ
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 1158 - 1158
  • [2] Phase I/II radioimmunotherapy with I-131 labeled chimeric monoclonal antibody cG250 in patients with metastasized renal cell carcinoma.
    Steffens, MG
    Boerman, OC
    Oosterwijk, E
    Oyen, WJG
    De Mulder, PHM
    Witjes, JA
    Oosterhof, GON
    Debruyne, FMJ
    Corstens, FHM
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 247P - 247P
  • [3] Phase I radioimmunotherapy of metastatic renal cell carcinoma with 131I-labeled chimeric monoclonal antibody G250
    Steffens, MG
    Boerman, OC
    de Mulder, PHM
    Oyen, WJG
    Buijs, WCAM
    Witjes, JA
    van den Broek, WJM
    Oosterwijk-Wakka, JC
    Debruyne, FMJ
    Corstens, FHM
    Oosterwijk, E
    [J]. CLINICAL CANCER RESEARCH, 1999, 5 (10) : 3268S - 3274S
  • [4] Radioimmunotargeting with I-131 labeled chimeric G250 monoclonal antibody in patients with renal cell carcinoma.
    Steffens, MG
    Boerman, OC
    Oosterwijk, E
    Oosterhof, GON
    Witjes, JA
    OosterwijkWakka, JC
    Koenders, E
    Debruyne, FMJ
    Corstens, FHM
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 740 - 740
  • [5] Traced labeled 131I chimeric clonal antibody (cG250) nv patients with renal cell carcinoma (RCC).
    Wiseman, GA
    Scott, AM
    Gansen, DN
    Lee, FT
    Hopkins, W
    Old, LJ
    Hoffman, EW
    Warnaar, S
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 310P - 310P
  • [6] Higher uptake in renal cell carcinoma (RCC) metastases with 111In-labeled chimeric monoclonal antibody G250 (cG250) than with 131I-cG250 in an intra-patient comparison.
    Brouwers, AH
    Buijs, WC
    Boerman, OC
    Oosterwijk, E
    De Mulder, PH
    Corstens, FH
    Mulders, PF
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 171P - 172P
  • [7] SCINTIGRAPHY OF RENAL-CELL CARCINOMA WITH I-131-LABELED MONOCLONAL-ANTIBODY (MAB) G250
    DIVGI, CR
    OOSTERWIJK, E
    SCOTT, AM
    BANDER, N
    OOSTERWIJK, J
    WELT, S
    LARSON, SM
    OLD, LJ
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1992, 19 (08): : 576 - 576
  • [8] Red marrow dosimetry after administration of I-131 labeled chimeric G250 monoclonal antibody (cG250) in patients with renal cell carcinoma, based on planar gamma camera images.
    Buijs, WCAM
    Steffens, MG
    Boerman, O
    Siegel, JA
    Oosterwijk, E
    Corstens, FHM
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 958 - 958
  • [9] Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma
    Divgi, CR
    Bander, NH
    Scott, AM
    O'Donoghue, JA
    Sgouros, G
    Welt, S
    Finn, RD
    Morrissey, F
    Capitelli, P
    Williams, JM
    Deland, D
    Nakhre, A
    Oosterwijk, E
    Gulec, S
    Graham, MC
    Larson, SM
    Old, LJ
    [J]. CLINICAL CANCER RESEARCH, 1998, 4 (11) : 2729 - 2739
  • [10] Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250
    Steffens, MG
    Boerman, OC
    OosterwijkWakka, JC
    Oosterhof, GON
    Witjes, JA
    Koenders, EB
    Oyen, WJG
    Buijs, WCAM
    Debruyne, FMJ
    Corstens, FHM
    Oosterwijk, E
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) : 1529 - 1537
12345